Skip to main content
Enlivex Therapeutics Ltd. logo

Enlivex Therapeutics Ltd. — Investor Relations & Filings

Ticker · ENLV ISIN · IL0011319527 TA Manufacturing
Open in API
Filings indexed 485 across all filing types
Latest filing 2023-11-10 Report Publication Anno…
Country IL Israel
Listing TA ENLV

About Enlivex Therapeutics Ltd.

https://enlivex.com/

Enlivex Therapeutics Ltd. is a clinical-stage macrophage reprogramming immunotherapy company. It is focused on developing Allocetra™, a universal, off-the-shelf cell therapy designed to treat immune system dysregulation. The therapy works by reprogramming macrophages to resolve hyper-inflammation. Enlivex is evaluating Allocetra™ in clinical trials for the treatment of multiple indications, including acute inflammatory diseases such as sepsis and chronic inflammatory conditions like osteoarthritis. The product candidate offers flexible administration options, including systemic intravenous infusion and targeted local injections.

Recent filings

Filing Released Lang Actions
Form 6-K- Third Quarter 2023 Financial Results
Report Publication Announcement Classification · 1% confidence The document explicitly states it is a 'Report of Periodic or Interim Report' under Israeli Securities Authority regulations. It mentions an attached file, '*6k09112023_isa.pdf*', and references the SEC Form '6-K' (which is used for reporting material events by foreign private issuers). Since this document is very short (1880 chars) and its primary function is to announce the availability of an attached periodic report (the 6-K filing), it fits the definition of a Report Publication Announcement (RPA) rather than the comprehensive Interim Report (IR) itself. The 'Menu vs Meal' rule dictates classifying announcements of reports as RPA if the document is brief and points to the main filing.
2023-11-10 English
6K-Court approved The Company’s share repurchase program was approved by Court
Regulatory Filings Classification · 1% confidence The document explicitly states it is a "Form 6-K Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934" for the month of November 2023. Form 6-K is used by foreign private issuers to report material information not required to be reported on a schedule or report under domestic reporting requirements. The content discusses the approval of a share repurchase program. Since Form 6-K is a general, periodic, or event-driven filing for foreign private issuers that doesn't fit the specific categories like 10-K (Annual Report) or ER (Earnings Release), it falls best under the general regulatory filing category, RNS (Regulatory Filings), which serves as a fallback for miscellaneous SEC filings not covered by the primary codes.
2023-11-08 English
6K-Court approved The Company’s share repurchase program was approved by Court
Report Publication Announcement Classification · 1% confidence The document is extremely short (1765 characters) and explicitly states, "Attached hereto is a report on*6k* *6k07112023_isa.pdf*". This structure indicates that the document itself is an announcement about the publication of another report (a Form 6-K, which is a general SEC filing for foreign private issuers, often used for material events). According to Rule 2, when a document is short and announces the availability of a report, it should be classified as a Report Publication Announcement (RPA). Since it is announcing the publication of a regulatory filing (6-K), RPA is the most appropriate classification based on the provided definitions, as it signals the release of information rather than containing the full substance of a specific report type like 10-K or IR.
2023-11-08 English
RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS HELD ON NOVEMBER 2 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled "Form 6-K" and reports on events occurring during "November 2023". The core content discusses the "Annual General Meeting of Shareholders" held on November 2, 2023, and confirms that shareholders voted on and approved proposals described in the Proxy Statement. Since the document reports the *results* of the shareholder vote from the AGM, it aligns best with the Declaration of Voting Results & Voting Rights Announcements (DVA). Although it mentions the AGM, the focus is on the outcome of the voting, not the presentation materials (AGM-R) or the proxy solicitation itself (PSI). The Form 6-K is a general filing, but the specific content dictates the classification.
2023-11-03 English
RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS HELD ON NOVEMBER 2 2023
Report Publication Announcement Classification · 1% confidence The document is extremely short (1765 characters) and explicitly states, "Attached hereto is a report on*6k* *6k02112023_isa.pdf*". This structure indicates that the document itself is an announcement about the publication of another report (a Form 6-K, which is a general SEC filing for foreign private issuers, often used for material events). According to Rule 2, when a document is short and announces the availability of a report, it should be classified as a Report Publication Announcement (RPA). The presence of the Israel Securities Authority and Tel Aviv Stock Exchange references confirms it is a regulatory filing announcement, but RPA is more specific for this announcement format.
2023-11-03 English
Annual General Meeting of Shareholders to be held on October 26, 2023
Proxy Solicitation & Information Statement Classification · 1% confidence The document explicitly contains the title "Annual General Meeting of Shareholders to be held on October 26, 2023" and is structured as a ballot/voting card, referencing proposals to be voted on at the AGM, and appointing a proxy. This content is characteristic of materials distributed to shareholders for voting purposes prior to or at the meeting. The definition for Proxy Solicitation & Information Statement (PSI) covers materials sent to shareholders to provide information and request votes for meetings. While it relates to the AGM, the primary function shown here is soliciting votes via a proxy card, which aligns best with PSI. If the document were the formal results, it would be DVA. If it were the full notice/information statement, it could also fit PSI, but the format strongly suggests a proxy card used for voting solicitation. Given the options, PSI is the most precise fit for a proxy voting document.
2023-10-27 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.